Nucs AI provides advanced AI-driven solutions that deliver precise, actionable insights for the clinical management of prostate cancer.
Total raised: $3.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.12.2024 | - | $3.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 12.12.2024 | Nucs AI: Pioneering the Future of Prostate Cancer Care with AI | In the ever-evolving landscape of medical technology, Nucs AI emerges as a beacon of hope. This Berlin-born, San Francisco-based startup has recently secured $3.5 million in seed funding. Their mission? To revolutionize the diagnosis and tr... |
| 11.12.2024 | Nucs AI raises $3.5M for prostate cancer diagnosis and treatment | Medtech startup Nucs AI has raised $3.5 million Seed funding. Founded in 2023 in Berlin and headquartered in San Francisco, Nucs AI uses precision medicine to diagnose and treat prostate cancer. With the number of new cases of prostate canc... |
| 11.12.2024 | Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics | What You Should Know: – Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of funding. – The company will use the funding to... |
| - | Nucs AI | “Nucs AI provides advanced AI-driven solutions that deliver precise, actionable insights for the clinical management of prostate cancer.” |